يعرض 1 - 10 نتائج من 14 نتيجة بحث عن '"MESH: Vaccines, Conjugate"', وقت الاستعلام: 1.20s تنقيح النتائج
  1. 1

    المساهمون: Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Physiologie, physiopathologie et thérapeutique (ED 394), Sorbonne Université (SU), Neovacs S.A [Paris], Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Neuropathologie expérimentale / Experimental neuropathology, Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), E.C. is the recipient of a CIFRE Ph.D. fellowship. B.B. was supported partly by a stipend from the Pasteur—Paris University (PPU) International Ph.D. program, and a fellowship from the French 'Fondation pour la Recherche Médicale FRM'. N.G. acknowledges funding from the European Research Council (ERC-2018-STG, No. 802041) and the INSERM ATIP-Avenir program, B.H.K. acknowledges funding from the National Institutes of Health (NIH) HL093735 and an Award from the American Asthma Foundation. L.L.R. acknowledges support from the ATIP-Avenir program, and P.B. from the European Research Council (ERC)–Seventh Framework Program (ERC-2013-CoG 616050). This work was supported by a grant from the French National Research Agency ANR-18-CE18-0023 'AllergyVACS', NEOVACS, the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Institut Pasteur., ANR-18-CE18-0023,AllergyVACS,Développement d'un vaccin thérapeutique pour les maladies allergiques(2018), European Project: 802041, European Project: 616050,EC:FP7:ERC,ERC-2013-CoG,MYELOSHOCK(2014), Gestionnaire, Hal Sorbonne Université, APPEL À PROJETS GÉNÉRIQUE 2018 - Développement d'un vaccin thérapeutique pour les maladies allergiques - - AllergyVACS2018 - ANR-18-CE18-0023 - AAPG2018 - VALID, ERC-2018-STG - 802041 - INCOMING, Role of myeloid cells, their mediators and their antibody receptors in allergic shock (anaphylaxis) using humanized mouse models and clinical samples - MYELOSHOCK - - EC:FP7:ERC2014-09-01 - 2019-08-31 - 616050 - VALID, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Toulouse [Toulouse], Institut Pasteur [Paris]-Université de Paris (UP), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Nature Communications
    Nature Communications, 2021, 12 (1), pp.2574. ⟨10.1038/s41467-021-22834-5⟩
    Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
    Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.2574. ⟨10.1038/s41467-021-22834-5⟩

    وصف الملف: application/pdf

  2. 2

    المساهمون: Chimie des Biomolécules - Chemistry of Biomolecules, Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], Université Paris Descartes - Paris 5 (UPD5), This work has received funding from the Institut Pasteur (GPF project FlexBiVac, Vaccinology Program), the French National Research Agency (grant # ANR-15-CE07-0019-01). Louis Antoine Barel (L.A.B) is the recipient of an ANR PhD fellowship (contract Nb ANR-15-CE07-0019-01), he is affiliated to the Médicament, Toxicologie, Chimie, Imageries (MTCI) doctoral school., ANR-15-CE07-0019,CarbUniVax,Synergie entre synthèse chimique et ingénierie d'enzymes pour le développement de vaccins glycoconjugués à large spectre(2015), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Human Vaccines & Immunotherapeutics
    Human Vaccines & Immunotherapeutics, Taylor & Francis, 2019, 15 (6), pp.1338-1356. ⟨10.1080/21645515.2019.1606972⟩
    Human Vaccines & Immunotherapeutics, 2019, 15 (6), pp.1338-1356. ⟨10.1080/21645515.2019.1606972⟩

  3. 3

    المساهمون: Harvard University [Cambridge], Laboratoire de Transmission, Contrôle et Immunobiologie des Infections - Laboratory of Transmission, Control and Immunobiology of Infection (LR11IPT02), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Oxford Vaccine Group, University of Oxford [Oxford]-Oxford NIHR Biomedical Research Centre-The Churchill hospital, National Institute for Communicable Diseases [Johannesburg] (NICD), Medical Research Council Unit The Gambia (MRC), University of Southampton, University of Edinburgh, University of Liverpool, National Medicines Institute - Narodowy Instytut Leków [Warsaw] (NIL), Pfizer Ltd France, Pfizer, Centers for Disease Control and Prevention [Atlanta] (CDC), Centers for Disease Control and Prevention, Emory Global Health Institute [Atlanta] (EGHI), Emory University [Atlanta, GA], Department of Microbiology [HKU], The University of Hong Kong (HKU), Johns Hopkins Bloomberg School of Public Health [Baltimore], Johns Hopkins University (JHU), The Wellcome Trust Sanger Institute [Cambridge], The study was funded in part by National Institute of Allergy and Infectious Disease award to WPH (R01 AI106786). The Global Pneumococcal Sequencing project is funded by The Bill and Melinda Gates Foundation (Grant OPP1034556).

    المصدر: PLoS Pathogens, Vol 14, Iss 11, p e1007438 (2018)
    Azarian, T, Mitchell, P K, Georgieva, M, Thompson, C M, Ghouila, A, Pollard, A J, von Gottberg, A, du Plessis, M, Antonio, M, Kwambana-Adams, B A, Clarke, S C, Everett, D, Cornick, J, Sadowy, E, Hryniewicz, W, Skoczynska, A, Moïsi, J C, McGee, L, Beall, B, Metcalf, B J, Breiman, R F, Ho, P L, Reid, R, O'Brien, K L, Gladstone, R A, Bentley, S D & Hanage, W P 2018, ' Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci ', PLoS Pathogens, vol. 14, no. 11, pp. e1007438 . https://doi.org/10.1371/journal.ppat.1007438
    PLoS Pathogens
    PLoS Pathogens, Public Library of Science, 2018, 14 (11), pp.e1007438. ⟨10.1371/journal.ppat.1007438⟩
    PLOS PATHOGENS

    مصطلحات موضوعية: Serotype, MESH: Vaccines, Conjugate, Physiology, [SDV]Life Sciences [q-bio], Population Dynamics, Glycobiology, Biochemistry, Pneumococcal conjugate vaccine, Coalescent theory, Pneumococcal Vaccines, MESH: Pneumococcal Vaccines/immunology, Immune Physiology, Mobile Genetic Elements, MESH: Serotyping/methods, Genotype, Prevalence, Medicine and Health Sciences, MESH: Carrier State/epidemiology, MESH: Streptococcus pneumoniae/pathogenicity, Biology (General), MESH: Phylogeny, Clade, Phylogeny, MESH: Evolution, Molecular, Data Management, Genetics, Vaccines, 0303 health sciences, education.field_of_study, Immune System Proteins, Geography, MESH: Streptococcus pneumoniae/immunology, Genomics, Antigenic Variation, Recombinant Proteins, 3. Good health, Phylogenetics, Phylogeography, Streptococcus pneumoniae, Infectious Diseases, Biogeography, Carrier State, Research Article, medicine.drug, Computer and Information Sciences, Infectious Disease Control, Tetracycline, QH301-705.5, MESH: Bayes Theorem, Immunology, Population, Biology, Serogroup, Microbiology, Pneumococcal Infections, Evolution, Molecular, 03 medical and health sciences, Genetic Elements, MESH: Whole Genome Sequencing/methods, Polysaccharides, Microbial Control, MESH: Streptococcus pneumoniae/genetics, medicine, Humans, Evolutionary Systematics, MESH: Genetics, Population/methods, Serotyping, Antigens, education, MESH: Prevalence, Taxonomy, 030304 developmental biology, Pharmacology, Evolutionary Biology, Vaccines, Conjugate, MESH: Humans, Whole Genome Sequencing, Population Biology, 030306 microbiology, Ecology and Environmental Sciences, Transposable Elements, Biology and Life Sciences, Proteins, Bayes Theorem, MESH: Serogroup, MESH: Population Dynamics, RC581-607, MESH: Pneumococcal Infections/transmission, Genetics, Population, Carriage, Antibiotic Resistance, Earth Sciences, MESH: Pneumococcal Infections/immunology, Antimicrobial Resistance, Immunologic diseases. Allergy, Population Genetics

    وصف الملف: application/pdf; text

  4. 4

    المساهمون: Manchester Royal Infirmary, University of Manchester [Manchester], Instituto de Salud Pública de Chile (ISP), University of the East – Ramon Magsaysay Memorial Medical Center [Philippines], Norwegian Institute of Public Health [Oslo] (NIPH), University of the West of England [Bristol] (UWE Bristol), Malvinas Children's Hospital [Buenos Aires], Université Laval [Québec] (ULaval), National Institute of Public Health = Instituto Nacional de Salud Pública [Cuernavaca, Mexique] (INSP), Meningitis Research Foundation [Bristol], Confederation of Meningitis Organisations [Bristol] (CoMO), National Institute of Infectious Diseases [Tokyo], Dhaka Shishu Hospital [Bangladesh], Scientific Research Institute of Children's Infections [Saint-Petersburg, Russia], Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], University of Cambridge [UK] (CAM), Institute of Health Carlos III, National Institute for Communicable Diseases [Johannesburg] (NICD), FCM Santa Casa de São Paulo School of Medical Sciences [São Paulo], The GMI is funded by an educational grant from Sanofi Pasteur, however, the group is not led in any way by the company. GMI members determine meeting agenda items and lead the discussions and outputs. Medical writing support was provided by Shelley Lindley, PhD, of PAREXEL, which was funded by Sanofi Pasteur. R Borrow and J Findlow perform contract research on behalf of Public Health England for Baxter Biosciences, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur, and Sanofi Pasteur MSD. DA Caugant has performed in the past contract research on behalf of the Norwegian Institute of Public Health for Novartis, Pfizer, and Sanofi Pasteur. H Christensen has received an honorarium from Sanofi Pasteur for running a GMI modeling workshop paid to her employer. Furthermore, H Christensen is supported by the National Institute for Health Research [PDF-2012-05-245] and is a member of the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol, UK. S Sidorenko has received grants from Pfizer, outside the submitted work. P De Wals has received research grants and reimbursements of travel expenses from vaccine manufacturers including GlaxoSmithKline, Novartis, Sanofi Pasteur, and Pfizer, as well as from governmental agencies including the Quebec Ministry of Health and Social Services, Health Canada, and the Public Health Agency of Canada. J Carlos has received research grant support from GlaxoSmithKline, Novartis, and Sanofi Pasteur, however, no conflict of interest relevant to this manuscript is reported. M-K Taha performs contract research on behalf of Institut Pasteur for GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. C Trotter received a consulting payment from GlaxoSmithKline in 2013 for critical review of a health economic model of meningococcal vaccines and an honorarium from Sanofi Pasteur in 2015 for running a GMI modeling workshop. JA Vázquez Moreno performed contract research on behalf of Institute of Health Carlos III for Baxter Biosciences, GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. A von Gottberg received research funding from Pfizer. MAP Sáfadi has received grants to support research projects from GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. This work is produced by the authors under the terms of the research training fellowships issued by the NIHR. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, NIHR, the Department of Health, or Public Health England. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed., Global Meningococcal Initiative, Institut Pasteur [Paris] (IP)

    المصدر: Expert Review of Vaccines
    Expert Review of Vaccines, Expert Reviews (formerly Future Drugs), 2017, 16 (4), pp.313-328. ⟨10.1080/14760584.2017.1258308⟩
    Borrow, R, Alarcon, P, Carlos, J, Caugant, D, Christensen, H, Debbag, R, De Wals, P, Echániz-Aviles, G, Findlow, J, Head, C, Holt, D, Kamiya, H, Saha, S, Sidorenko, S, Taha, M-K, Trotter, C, Vázquez Moreno, J & Von Gottberg, A 2016, ' The global meningococcal initiative : global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection ', Expert Review of Vaccines, vol. 16, no. 4, pp. 313-328 . https://doi.org/10.1080/14760584.2017.1258308
    Expert Review of Vaccines, 2017, 16 (4), pp.313-328. ⟨10.1080/14760584.2017.1258308⟩

    مصطلحات موضوعية: 0301 basic medicine, Epidemiology, MESH: Meningococcal Vaccines/immunology, MESH: Global Health, Neisseria meningitidis, medicine.disease_cause, Global Health, MESH: Immunization Programs, Disease Outbreaks, MESH: Neisseria meningitidis/immunology, MESH: Meningococcal Infections/prevention & control, MESH: Meningococcal Infections/epidemiology, 0302 clinical medicine, prevention, MESH: Meningococcal Vaccines/therapeutic use, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Drug Discovery, Global health, 030212 general & internal medicine, MESH: Incidence, Global Meningococcal Initiative, MESH: Vaccines, Conjugate/immunology, Incidence, MESH: Meningitis, Meningococcal/immunology, MESH: Disease Outbreaks/prevention & control, 3. Good health, Vaccination, outbreaks, surveillance, Molecular Medicine, African meningitis belt, serogroups, 030106 microbiology, Immunology, Meningococcal Vaccines, Meningococcal vaccine, MESH: Meningitis, Meningococcal/epidemiology, Meningitis, Meningococcal, Meningococcal disease, 03 medical and health sciences, Environmental health, MESH: Meningitis, Meningococcal/prevention & control, Epidemiology, Global Meningococcal Initiative, meningococcal disease, MenW, Neisseria meningitidis, outbreaks, prevention, serogroups, surveillance, vaccination, medicine, Humans, MESH: Vaccines, Conjugate/therapeutic use, MenW, Pharmacology, meningococcal disease, Vaccines, Conjugate, MESH: Humans, business.industry, Immunization Programs, Outbreak, medicine.disease, vaccination, Meningococcal Infections, Carriage, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Neisseria meningitidis/classification, business, MESH: Meningococcal Infections/immunology

    وصف الملف: application/pdf

  5. 5

    المساهمون: Service de Maladies Infectieuses et Tropicales [CHU Bicêtre], AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Infections Bactériennes Invasives, Institut Pasteur [Paris], Néphrologie [CHU Bicêtre], Université Paris-Sud - Paris 11 - Faculté de médecine (UP11 UFR Médecine), Université Paris-Sud - Paris 11 (UP11), Centre Hépato-Biliaire [Hôpital Paul Brousse] (CHB), Hôpital Paul Brousse-Assistance Publique - Hôpitaux de Paris, CIC - Biotherapie - AP-HP (cochin - Pasteur), Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP)

    المصدر: Transplant Infectious Disease
    Transplant Infectious Disease, Wiley, 2015, 17 (2), pp.322-327. ⟨10.1111/tid.12359⟩
    Transplant Infectious Disease, 2015, 17 (2), pp.322-327. ⟨10.1111/tid.12359⟩

    مصطلحات موضوعية: Graft Rejection, Male, MESH: Vaccines, Conjugate, Neisseria meningitidis, Serogroup C, Neisseria meningitidis, MESH: Meningococcal Infections, medicine.disease_cause, MESH: Meningococcal Vaccines, MESH: Kidney Transplantation, Cohort Studies, meningococcal vaccine, Neisseria meningitidis, Serogroup A, MESH: Antibodies, Bacterial, MESH: Immunocompromised Host, Prospective Studies, solid organ transplantation, MESH: Cohort Studies, MESH: Aged, education.field_of_study, MESH: Middle Aged, Immunogenicity, Middle Aged, Antibodies, Bacterial, 3. Good health, Vaccination, Infectious Diseases, Female, MESH: Immunosuppressive Agents, Neisseria meningitidis, Serogroup Y, Immunosuppressive Agents, Adult, MESH: Liver Transplantation, MESH: Transplant Recipients, Population, Meningococcal Vaccines, MESH: Graft Rejection, Meningococcal vaccine, immunization, Meningococcal disease, MESH: Neisseria meningitidis, Immunocompromised Host, Neisseria meningitidis, Serogroup W-135, MESH: Neisseria meningitidis, Serogroup A, Conjugate vaccine, MESH: Neisseria meningitidis, Serogroup C, medicine, Humans, education, Aged, Transplantation, Vaccines, Conjugate, MESH: Humans, business.industry, MESH: Adult, antibody response, MESH: Neisseria meningitidis, Serogroup W-135, medicine.disease, Kidney Transplantation, Virology, Transplant Recipients, MESH: Prospective Studies, MESH: Male, Liver Transplantation, Meningococcal Infections, Immunization, Immunology, [SDV.IMM.VAC]Life Sciences [q-bio]/Immunology/Vaccinology, MESH: Neisseria meningitidis, Serogroup Y, business, MESH: Female

  6. 6

    المساهمون: Agence de Médecine Préventive, Ministry of Health [Togo], Agence de Médecine Préventive [Burkina Faso], École des Hautes Études en Santé Publique [EHESP] (EHESP), Département Méthodes quantitatives en santé publique (METIS), Institut Pasteur [Paris], Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM), This study was funded by an Investigator Initiated Research grant from Pfizer (WS951939). BG, HT, BMNL, JCM work for AMP and receive research funding from Pfizer and GSK, manufacturers of pneumococcal conjugate vaccines., We thank the PneumoTone study team at AMP for their continuous work for the success of the project: C Bouyssou, E Espie, S Kroman, A Leblond, D Mounkoro, M Ouedraogo, E Rosser, O Sanou, F Sawadogo and L Tidjani. We thank clinicians and laboratory staff at Centre Hospitalier Regional-Dapaong, Hopital Pediatrique Yendube, Clinique Win’Pang, Centre Medical des Armees, Polyclinique-Dapaong and Centre Hospitalier Prefectoral-Cinkasse, Pr Ndakena, Pr Atakouma and Pr Prince-David for expert input on all scientific aspects of the study, B Chandler for chest X-ray interpretation, JN Telles, G Paranhos-Baccala, A Rajoharison, M Van der Linden, M Kheir-Taha and M Slack for molecular testing of blood and nasopharyngeal specimens and characterization of bacterial strains., Institut Pasteur [Paris] (IP), Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)

    المصدر: PLoS ONE
    PLoS ONE, Public Library of Science, 2017, 12 (1), pp.e0170412. ⟨10.1371/journal.pone.0170412⟩
    PLoS ONE, 2017, 12 (1), pp.e0170412. ⟨10.1371/journal.pone.0170412⟩
    PLoS ONE, Vol 12, Iss 1, p e0170412 (2017)

  7. 7

    المساهمون: Centre de Recherche Médicale et Sanitaire (Niamey, Niger) (CERMES), Réseau International des Instituts Pasteur (RIIP), Bill & Melinda Gates Foundation and the Wellcome Trust, The MenAfriCar consortium : Armauer Hansen Research Institute, Addis Ababa, Ethiopia: Oumer Ali, Abraham Aseffa (PI), Ahmed Bedru, Tsehaynesh Lemma, Tesfaye Moti, Alemayehu Worku, Haimanot Guebre Xabher, Lawrence Yamuah. Centre de Recherche Médicale et Sanitaire (CERMES), Niamey, Niger (Member of the International Network of Pasteur Institutes): Rahamatou Moustapha Boukary, Jean-Marc Collard (PI), Ibrahim Dan Dano, Ibrahim Habiboulaye, Bassira Issaka, Jean-François Jusot, Sani Ousmane, Issoufa Rabe. Centers for Disease Control, Atlanta, USA: Tom Clark, Leonard Mayer. Centre de Support en Santé International (CSSI), N'Djamena, Chad: Jean Pierre Gami, Kadidja Gamougam, Boulotigam Kodbesse, Nathan Naibei, Cyriaque Ngadoua, Lodoum Mbainadji, Daugla Doumagoum Moto (PI), Maxime Narbé, Jacques Toralta. Centre pour les Vaccins en Développement, Bamako, Mali: Abdoulaye Berthe, Mahamadou Keita, Kanny Diallo, Uma Onwuchekwa, Samba O Sow (PI), Boubou Tamboura, Awa Traore, Alou Toure. Department of Community Medicine, University of Maiduguri, Maiduguri, Nigeria: Mary Amodu, Omeiza Beida, Galadima Gadzama, Babatunji Omotara (PI), Zailani Sambo, Shuaibu Yahya. Faculty of Infectious Disease, London School of Hygiene & Tropical Medicine, London, UK: Daniel Chandramohan, Brian Greenwood, Musa Hassan-King, Olivier Manigart, Maria Nascimento, James Stuart, Arouna Woukeu. Health Protection Agency Vaccine Evaluation Unit, Manchester, UK: Xilian Bai, Ray Borrow, Helen Findlow. Institut de Recherche pour le Développement, Dakar, Senegal: Serge Avalo, Hubert Bassene, Aldiouma Diallo (PI), Marietou Dieng, Souleymane Doucouré, Jules François Gomis, Assane Ndiaye, Cheikh Sokhna, Jean François Trape. Navrongo Health Research Centre, Navrongo, Ghana: Bugri Akalifa, Abudulai Forgor, Abrahan Hodgson (PI), Isaac Osei, Stephen Quaye, John Williams, Peter Wontuo. Princeton University USA: Nicole Basta (Formerly University of Washington)(supported by NIH grants 2R37A1032042 and R03A1092121). School of Social and Community Medicine, University of Bristol, Bristol, UK: Thomas Irving, Caroline Trotter. University of Oxford, UK: Julia Bennett, Marietou Dieng, Dorothea Hill, Odile Harrison, Lisa Rebbetts, Martin Maiden, Yenenesh Tekletsion, Eleanor Watkins.

    المصدر: Tropical Medicine & International Health
    Tropical Medicine & International Health, John Wiley & Sons Ltd, 2013, 18 (8), pp.968-978. ⟨10.1111/tmi.12125⟩

    مصطلحات موضوعية: MESH: Vaccines, Conjugate, International Cooperation, Pilot Projects, Meningococcal Disease, MESH: Pharynx, Neisseria meningitidis, MESH: Africa, MESH: Immunization Programs, Polymerase Chain Reaction, MESH: Meningococcal Vaccines, 0302 clinical medicine, Neisseria meningitidis, Serogroup A, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Child, 030212 general & internal medicine, Child, 0303 health sciences, MESH: Program Evaluation, MESH: Meningitis, Meningococcal, MESH: Enzyme-Linked Immunosorbent Assay, MESH: Infant, 3. Good health, Infectious Diseases, MESH: Young Adult, Child, Preschool, meningococcus, Carrier State, MESH: Carrier State, Adult, Adolescent, MenAfriCar, Enzyme-Linked Immunosorbent Assay, Meningitis, Meningococcal, Specimen Handling, 03 medical and health sciences, Young Adult, MESH: Cross-Sectional Studies, meningococcal carriage, MESH: Neisseria meningitidis, Serogroup A, Humans, MESH: Specimen Handling, Epidemics, MESH: Epidemics, 030304 developmental biology, MESH: Adolescent, Vaccines, Conjugate, MESH: Humans, Immunization Programs, MESH: Child, Preschool, Public Health, Environmental and Occupational Health, Infant, MESH: Adult, MESH: Polymerase Chain Reaction, meningococcal vaccines, MESH: Pilot Projects, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, MESH: International Cooperation, Cross-Sectional Studies, Africa, Pharynx, Parasitology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Program Evaluation

  8. 8

    المساهمون: Centre de Recherche Médicale et Sanitaire (Niamey, Niger) (CERMES), Réseau International des Instituts Pasteur (RIIP), This work was financially supported by Sanofi Pasteur (contract Men07) and by the French Ministry of Foreign Affairs (FSP No. 2005-174).

    المصدر: PLoS ONE
    PLoS ONE, Public Library of Science, 2013, 8 (3), pp.e60432. ⟨10.1371/journal.pone.0060432⟩
    PLoS ONE, Vol 8, Iss 3, p e60432 (2013)

  9. 9

    المساهمون: University of Pittsburgh (PITT), Pennsylvania Commonwealth System of Higher Education (PCSHE), Boston University School of Medicine (BUSM), Boston University [Boston] (BU), National University of Singapore (NUS), Norwegian Institute of Public Health [Oslo] (NIPH), FCM Santa Casa de São Paulo School of Medical Sciences [São Paulo], Meningococcal Reference Laboratory [Madrid], Institute of Health Carlos III, PATH Europe [Ferney Voltaire], National Institute for Communicable Diseases [Johannesburg] (NICD), Manchester Royal Infirmary, University of Manchester [Manchester], University of Pennsylvania, Members of the GMI Chairman: Stanley Plotkin, MD (University of Pennsylvania, Doylestown, PA, USA). Steering Committee: Carl Frasch, PhD (Frasch Biologics Consulting, Martinsburg, WV, USA), Sunil Gupta, MBBS, MD (National Institute of Communicable Diseases, Delhi, India), Lee H. Harrison, MD (University of Pittsburgh, Pittsburgh, PA, USA), Ziad Memish, MD (Ministry of Health, Riyadh, Saudi Arabia), Andrew J. Pollard, FRCPCH, PhD (University of Oxford, Oxford, UK), Muhamed-Kheir Taha, MD, PhD (Institut Pasteur, Paris, France), Julio Vazquez, PhD (Institute of Health Carlos III, Madrid, Spain), Anne von Gottberg, MBBCh (National Institute for Communicable Diseases, Johannesburg, South Africa). Summit Members: Richard Adegbola, MSc, PhD (Bill and Melinda Gates Foundation, Seattle, WA, USA), Colin Block, MBBCh, PhD (Hadassah-Hebrew University Medical Centre, Jerusalem, Israel), Ray Borrow, PhD, FRCPath (Health Protection Agency, Manchester, UK), Tom Clark, MD, MPH (Centers for Disease Control and Prevention, Atlanta, GA, USA), Benoit Dervaux, PhD (Faculty of Medicine, University 'Droit et Santé', Lille, France), Johan Holst, PhD, MSc (Norwegian Institute of Public Health, Oslo, Norway), Sheldon Kaplan, MD (Baylor College of Medicine, Houston, TX, USA), Marc LaForce, MD (Meningitis Vaccine Project, Ferney, France), Xiaofeng Liang, MD (National Immunization Program, China CDC, Beijing, China), Diana Martin, PhD (Institute of Environmental Science and Research, Poriru, New Zealand), Stephen Pelton, MD (Boston University Schools of Medicine and Public Health, Boston, MA, USA), Marco Safadi, MD (FCM Da Santa Casa de São Paulo, São Paulo, Brazil), Samir Saha, PhD (Bangladesh Institute of Child Health, Dhaka, Bangladesh), Franklin Sotolongo, MD (Finlay Institute, Havana, Cuba), Irina Stanislavovna Koroleva, MD, PhD (Central Research Institute of Epidemiology, Moscow, Russia), Annelies Wilder-Smith, MD, PhD, MIH (National University of Singapore, Singapore)., University of Pennsylvania [Philadelphia]

    المصدر: Vaccine
    Vaccine, 2011, 29 (18), pp.3363-3371. ⟨10.1016/j.vaccine.2011.02.058⟩
    Vaccine, Elsevier, 2011, 29 (18), pp.3363-3371. ⟨10.1016/j.vaccine.2011.02.058⟩

  10. 10

    المساهمون: Biologie et physiopathologie cutanées : expression génique, signalisation et thérapie, Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM), Immunité muqueuse et vaccination, COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UCA), Centre d'Immunologie de Marseille - Luminy (CIML), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Mucosal Immunology Section, International Vaccine Institute (IVI), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-IFR50-Université Côte d'Azur (UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: Journal of Immunology
    Journal of Immunology, 2010, 184 (9), pp.4842-51. ⟨10.4049/jimmunol.0901695⟩
    Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2010, 184 (9), pp.4842-51. ⟨10.4049/jimmunol.0901695⟩